Actinium Pharmaceuticals reported $-15.94M in Net Income for its fiscal quarter ending in March of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Actinium Pharmaceuticals USD -15.94M 9.29M Mar/2025
Amgen USD 1.33B 1.88B Dec/2025
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -24.39M 17.27M Mar/2025
Pfizer USD -1.65B 5.19B Dec/2025